Concierge MD Review

What Concierge MD charges

• NAD+: $199/mo — starting at, per month on a monthly subscription; the order form on the same page prices the same 500 mg vial at $249.00 as a one-time purchase, and offers a 1000 mg vial as a separate selection
• NAD+: $249/mo — starting at, for a 1-Month Supply bought once rather than on a subscription, in the seller's own words
• Sermorelin: $199/mo — starting at, per month on a monthly subscription; the same page also lists a 3-Month Supply at $899.00 in total, which is not a monthly rate and is not recorded as one
• Sermorelin: $299/mo — starting at, for a 1-Month Supply bought once; the same seller's NAD+ page attaches this figure to a sermorelin monthly subscription instead, which is not what the sermorelin page charges

The subscription and the single month, side by side

The NAD+ page prices a monthly subscription and a one-month purchase. The order form on the same page names what each buys: one vial at five hundred milligrams, with a thousand-milligram vial offered as a separate selection.

The sermorelin page does the same, adding a three-month supply priced as a total rather than as a rate. That total is not recorded here as a monthly figure, because it is not one.

Publishing both lanes makes the cost of not committing visible, which is the single most useful thing a seller in this market can print.

Both pages also name the delivery formats. Sermorelin is offered as a self-injection and as a troche.

Two pages on one site that disagree about a price

The NAD+ page's order form lists a sermorelin monthly subscription as an add-on at a figure higher than the sermorelin page charges for a subscription.

On the sermorelin page, that same figure is the price of a single month bought once. The subscription rate there is lower.

A row built from the add-on list would have carried a monthly rate this seller does not charge. The figures recorded here come from each compound's own page.

Add-on prices are also discounted as add-ons, and the form says a subscription discount applies to the first month only. Those are not standalone prices and are not recorded as any.

Who you are buying from, and where

The footer carries a trading name and nothing else. The terms carry a table of third-party medical providers instead, naming a parent company and about two dozen per-state professional corporations.

Publishing that table is more disclosure than most sellers here offer, and it still does not answer the question a reader asks, which is who takes the payment.

The same page says the brand offers coverage throughout the United States, while the table names roughly thirty places. Those two statements do not reconcile into a list, so no state footprint is recorded on this row.

The order form's state menu lists every state and the District of Columbia. That is a form control and not a coverage claim, and reading it as one would produce a fifty-state footprint this seller never published.

The same operator runs another brand, and four more compounds sit here unpriced

Several of the professional corporations in that table trade under a second brand name, so the two brands share an operator. Anyone comparing them is comparing one company against itself.

The catalog reaches beyond the two compounds compared here. Its own page list carries CJC-1295, GHK-Cu, PT-141 and a glutathione injection, and its order form offers a GHK-Cu cream and a PT-141 nasal spray as add-ons.

Those four standalone pages are not compared on this site, because no figure for them was established. Declaring a compound without a figure would make a board tell a reader this seller publishes no price for it, which nothing here established.

Twenty-four of the forty-five sellers here publish no state list at all, and this is one of them. Ten of the forty-five sellers here name the facility that fills an order; this is one of the thirty-five that do not.

How we verified this

• Read both compound pages as rendered text in a browser, because a plain fetch is refused by this host for real pages and for a nonsense path alike.
• Confirmed the browser answers a nonsense path with this seller's own not-found page in the same pass, and confirmed that its throttling response is a different, much shorter body than that page.
• Took each figure from its own compound's page, and recorded the add-on figures on the other page as add-ons rather than as prices.
• Read the strength, the frequency and the add-on options out of the inline order form, which is on the public page and needs nothing entered to reveal them.
• Declined to record the three-month sermorelin total as a monthly rate.
• Read the terms' provider table in full and compared it against the coverage sentence on the same page, then recorded no state footprint because the two do not reconcile.
• Treated the order form's state menu as a form control rather than a coverage list.
• Confirmed the second brand's professional corporations appear inside this seller's own provider table, which is why the two are treated as one operator.
• Left four compounds undeclared rather than declaring them with no figure, because their pages were not read in this pass.
• Searched the published federal warning-letter record for the brand across the years that record covers, and found no letter to it. That record does not include untitled letters.